Razvan Grigorie
Overview
Explore the profile of Razvan Grigorie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu J, Wang F, Zhang W, Ren Y, Yang T, Ratti F, et al.
Ann Surg Oncol
. 2025 Jan;
32(4):2499-2500.
PMID: 39863801
No abstract available.
2.
Lu J, Wang F, Zhang W, Ren Y, Yang T, Ratti F, et al.
Ann Surg Oncol
. 2024 Dec;
32(4):2446-2455.
PMID: 39730966
Background: We sought to define whether and how hepatic ischemia/reperfusion (I/R) as manifested by perioperative aspartate aminotransferase (AST) and alanine aminotransaminase (ALT) levels impact long-term outcomes after curative-intent resection of...
3.
Wang F, Lu J, Yang T, Ren Y, Ratti F, Marques H, et al.
Ann Surg
. 2024 Feb;
281(4):624-631.
PMID: 38348655
Objectives: To define how dynamic changes in pre versus postoperative serum aspartate aminotransferase (AST) and alanine transaminase (ALT) levels may impact postoperative morbidity after curative-intent resection of hepatocellular carcinoma (HCC)....
4.
Zhang X, Xue F, Bagante F, Ratti F, Marques H, Silva S, et al.
J Gastrointest Surg
. 2021 Nov;
26(5):1021-1029.
PMID: 34797558
Objectives: To identify the preoperative risk factors for prediction of non-transplantable recurrence (NTR) after tumor resection for early-stage hepatocellular carcinoma (HCC) to assist in patient selection relative to upfront liver...
5.
Wei T, Zhang X, Bagante F, Ratti F, Marques H, Silva S, et al.
Ann Surg Oncol
. 2021 Aug;
29(1):315-324.
PMID: 34378089
Background: Postoperative infectious complications may be associated with a worse long-term prognosis for patients undergoing surgery for a malignant indication. The current study aimed to characterize the impact of postoperative...
6.
Wei T, Zhang X, Xue F, Bagante F, Ratti F, Marques H, et al.
Ann Surg Oncol
. 2021 May;
28(12):7624-7633.
PMID: 34019181
Backgrounds: Extrahepatic recurrence of hepatocellular carcinoma (HCC) after surgical resection is associated with unfavorable prognosis. The objectives of the current study were to identify the risk factors and develop a...
7.
Wei T, Zhang X, Bagante F, Ratti F, Marques H, Silva S, et al.
Ann Surg Oncol
. 2020 Nov;
28(2):797-805.
PMID: 33249525
Background: The impact of tumor necrosis relative to prognosis among patients undergoing curative-intent resection for hepatocellular carcinoma (HCC) remains ill-defined. Methods: Patients who underwent curative-intent resection for HCC without any...
8.
Tsilimigras D, Mehta R, Paredes A, Moris D, Sahara K, Bagante F, et al.
Ann Surg
. 2020 Sep;
272(4):574-581.
PMID: 32932309
Objective: The objective of the current study was to define surgical outcomes after resection of multinodular hepatocellular carcinoma (HCC) beyond the Milan criteria, and develop a prediction tool to identify...
9.
Wei T, Zhang X, Bagante F, Ratti F, Marques H, Silva S, et al.
J Gastrointest Surg
. 2020 Mar;
25(1):125-133.
PMID: 32128681
Background: To define early versus late recurrence based on post-recurrence survival (PRS) among patients undergoing curative resection for hepatocellular carcinoma (HCC). Methods: Patients who underwent curative-intent resection for HCC between...
10.
Tsilimigras D, Mehta R, Merath K, Bagante F, Paredes A, Farooq A, et al.
HPB (Oxford)
. 2020 Jan;
22(9):1305-1313.
PMID: 31889626
Background: Composite measures such as "Textbook Outcome" (TO) may be superior to individual quality metrics to assess surgical care and hospital performance. However, the incidence and factors associated with TO...